References
- Al-Dabbagh S. G., Idle J. R., Smith R. L. Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains. Journal of Pharmacy and Pharmacology 1981; 33: 161–164
- Boobis A. R., Seddon C. E., Davies D. S. Bufaralol 1′-hydroxylase activity of the rat. Strain differences and the effects of inhibitors. Biochemical Pharmacology 1986; 35: 2961–2965
- Boobis A. R., Edwards R. J., Singleton A., Sesardic D., Murray B., Speirs C. J., Murray S., Kobayashi S., Davies S. The contribution of polymorphic isozymes of cytochrome P-450 to the pharmacokinetics and toxicity of foreign compounds in man. Microsomes and Drug Oxidations, Proceedings of the 7th International Symposium, J. O. Miners, D. J. Birkett, R. Drew, B. K. May, M. E. McManus. Taylor & Francis, London 1988; 216–223
- Gonzalez F. J., Matsunaga T., Nagata K., Meyer U. A., Nebert D. W., Pastewka J., Kozak C. A., Gillette J., Gelboin H. V., Hardwick J. P. Debrisoquine 4-hydroxylase: characterization of a new P-450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. DNA 1987; 6: 149–161
- Hawes E. M., Roy S. D., McKay G., Midha K. K. Methoxyphenamine O-demethylase and 5-hydroxylase: A GLC-ECD assay to study their activities and their inhibition by debrisoquine and sparteine. Pharmacology and Therapeutics 1987; 33: 73–77
- Inaba T., Jurima M., Mahon W. A., Kalow W. In vitro inhibition studies of two isozymes of human liver cytochrome P-450: mephenytoin p-hydroxylase and sparteine monooxygenase. Drug Metabolism and Disposition 1985; 13: 443–448
- Kobayshi S., Murray S., Watson D., Sesardic D., Davies D. S., Boobis A. R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology 1989; 38: 2795–2799
- Larrey D., Distelrath L. M., Damman G. A., Wilkinson G. R., Guengerich F. P. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry 1984; 23: 2787–2795
- McKay G., Cooper J. K., Hawes E. M., Roy S. D., Midha K. K. Identification of new secondary metabolites of methoxyphenamine in man. Xenobiotica 1983; 13: 257–264
- Muralidharan G., Midha K. K., McKay G., Hawes E. M., Inaba T. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism. Xenobiotica 1989; 19: 189–197
- Muralidharan G., Hawes E. M., McKay G., Korchinski E. D., Midha K. K. Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. European Journal of Clinical Pharmacology 1991, In press
- Nielsen M. D., Brøsen K., Gram L. F. A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man. British Journal of Clinical Pharmacology 1990; 29: 299–304
- Otton S. V., Inaba T., Kalow W. Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs. Life Sciences 1984; 34: 73–80
- Roy S. D., Hawes E. M., McKay G., Korchinski E. D., Midha K. K. Metabolism of methoxyphenamine in extensive and poor metabolizers of debrisoquine. Clinical Pharmacology and Therapeutics 1985a; 38: 128–133
- Roy S. D., Hawes E. M., McKay G., Hubbard J. W., Midha K. K. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes. Canadian Journal of Physiology and Pharmacology 1985b; 63: 778–781
- Roy S. D., Hawes E. M., Midha K. K. Influence of urinary pH on the disposition of methoxyphenamine and three metabolites in humans. Journal of Pharmaceutical Sciences 1987; 76: 427–432
- Steiner E., Dumont E., Spina E., Dahlqvist R. Inhibition of desipramine 2-hydroxylation by quinidine and quinine. Clinical Pharmacology and Therapeutics 1988; 43: 577–581
- Suzuki T., Chiang H.-J. F., Yanaura S., Yoshida T., Kuroiwa Y. Studies on the mechanism of interaction between methamphetamine and quinine in rats. Journal of Pharmacobio-Dynamics 1986; 9: 234–238
- Von Bahr C., Spina E., Birgersson C., Ericsson V., Göransson M., Henthorn T., Sjöqvist F. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes. Biochemical Pharmacology 1985; 34: 2501–2505